Published in Volume
121, Issue 1 (January 4, 2011)
J Clin Invest. 2011;121(1):456–456.
doi:10.1172/JCI45846.
Copyright © 2011, American Society for Clinical
Investigation
Corrigendum
Palmitic acid mediates hypothalamic insulin resistance by altering
PKC-θ subcellular localization in rodents
Stephen C. Benoit, Christopher J. Kemp, Carol F. Elias, William Abplanalp, James P. Herman, Stephanie Migrenne, Anne-Laure Lefevre, Céline Cruciani-Guglielmacci, Christophe Magnan, Fang Yu, Kevin Niswender, Boman G. Irani, William L. Holland and Deborah J. Clegg
First published December 22, 2010
Original citation: J. Clin. Invest. 2010;120(1):394.
doi:10.1172/JCI36714C1.
Citation for this corrigendum: J. Clin. Invest. 2011;121(1):456. doi:10.1172/JCI45846.
In the Methods section titled “Fatty acid infusion,” the dose of
fatty acids delivered centrally was given incorrectly. The correct sentence appears
below.
The cannula was connected via a polyethylene catheter to a subcutaneous osmotic minipump
(Alza Corporation) filled with either palmitic or oleic acid (equimolar concentrations,
50 μmol/l; Sigma-Aldrich) or vehicle (PBS) for continuous infusion over 3
days.
The authors regret the error.
